The firm will use Jefferson Health’s providers, care coordinators and patients to evaluate the blood-based MCED test’s safety and efficacy, the report said.
Jefferson Health serves more than 125,000 adults who are eligible for cancer screening. The health system and Exact Sciences plan to publish the results of the research, according to the report.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
